http://pennstatehershey.org According to the National Institutes of Health, as much as 10 percent of the U.S. population may have Restless Legs Syndrome. With Restless Legs Syndrome Awareness Week being observed across the country, we got some answers from Dr. Max Lowden who heads the RLS Clinic at Penn State Milton S. Hershey Medical Center. In this video, he explains the symptoms and some of the cutting-edge treatments being made available to RLS patients at Penn State Hershey.
Share this Video
Related Videos In Neuromuscular Diseases
Sabrina Paganoni, AAN 2021: Treatment Options for the Management of ALS
It was a pleasure to interview Sabrina Paganoni (Harvard Medical School, Boston, MA, USA) to discuss treatment options for the management of amyotrophic lateral sclerosis (ALS). The abstract entitled: ‘Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS’ was presented at the American Academy of Neurology Virtual Annual Meeting 2021. Questions: Could […]
Sabrina Paganoni, AAN 2021: CENTAUR Trial of AMX0035 for ALS
It was a pleasure to meet with Sabrina Paganoni (Harvard Medical School, Boston, MA, USA) to discuss the CENTAUR study findings, and where AMX0035 is likely to be placed in the treatment paradigm for amyotrophic lateral sclerosis (ALS). The abstract entitled: ‘Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS’ was presented […]
Tahseen Mozaffar: PROPEL Study Results
TouchNEUROLOGY caught up with Tahseen Mozaffar (University California, Irvine, CA, USA) to discuss the results from the PROPEL study (NCT03729362) investigating the use of AT-GAA for the treatment of late-onset Pompe disease. Questions: Could you tell us a little about late onset Pompe disease and the unmet needs in its treatment? (0:15) What is AT-GAA […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!